New developments in endometriosis from a molecular and cellular standpoint

New developments in endometriosis from a molecular and cellular standpoint By Eylül GÜN

Researchers are making significant progress in endometriosis regarding molecular and cellular research, with collaborative efforts by clinicians, scientists, surgeons, and biostatisticians. Laganà et al. from Italy wrote an editorial regarding the recent special issue called "Molecular and Cellular Advances in Endometriosis Research…

Key Points Lay Summary

White blood cell neutrophils link to immunosuppressive environment in ovarian endometrioma

White blood cell neutrophils link to immunosuppressive environment in ovarian endometrioma By Yu Yu

Recently the contribution of neutrophils to the pathogenesis of endometriosis has been suggested. Several observations fuelled this suggestion, such as the accumulation of neutrophils in the peritoneal fluid of ovarian endometriosis; neutrophil extracellular traps were found in the peritoneal fluid of…

Key Points Lay Summary

Targeted therapy biomarkers in endometriosis associated ovarian carcinomas

Targeted therapy biomarkers in endometriosis associated ovarian carcinomas By Serdar Balci

Endometriosis in ovaries is a known precursor of endometrioid and clear cell carcinomas. They may be resistant to classical therapies. Researchers search for alternative and targeted therapy options. This study, from the University of Campinas, Campinas, São Paulo, Brazil, will be…

Key Points Lay Summary

Programmed-cell death pathway and immune dysfunction in endometriosis

Programmed-cell death pathway and immune dysfunction in endometriosis By Irem Onur

Endometriosis is an estrogen-dependent, immune-associated disease. Women with endometriosis have different proportions of the activated forms of immunocompetent cells, such as T cells and macrophages compared to those from women without. Immune cell dysfunction in the uterine and abdominal cavity…

Key Points Lay Summary